Gain detailed insights into the trading activity of Congress members for Tempus AI on our government trades page. Stay updated on how elected officials are investing in TEM.

Tempus AI - Government Trades

Tempus AI

Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.

Recent Gains

News

Pre-Market Outlook

Markets

Movers

Trading Ideas

ATPC

BDMD

CGBS

CRKN

DWTX

New Oriental Education & Technology Group

ELTX

EONR

FFWM

GOEV

IROQ

ORKT

RSKD

RYAM

SWKH

TMCI

TPET

TTGT

VATE

Why INNOVATE Shares Are Trading Higher By Over 19%; Here Are 20 Stocks Moving Premarket

Cathie Wood's Monday Moves: $4.8M Spotify Stock Sale Meets $4.7M Pinterest Shopping Spree

Equities

Tech

ETFs

ACCD

ARKF

ARKG

ARKK

CRSP

IBTA

PATH

RBLX

RDDT

Ark Invest made significant trades involving Tempus AI, CRISPR Therapeutics, UiPath, Roblox, Reddit, Accolade, and Ibotta. ARKG and ARKK funds bought shares, while ARKW and ARKF funds sold shares.

Cathie Wood&#39;s Ark Invest Is Betting Big On This AI Darling And No It&#39;s Not Nvidia

ADPT

CDNA

PLTR

VCYT

Cathie Wood-led Ark Invest sold 140,518 shares of Palantir and bought shares of Tempus AI Inc. The total value of the trades is about $9.1 million.

Cathie Wood&#39;s Ark Invest Trims Palantir Again As Peter Thiel Co-Founded Firm&#39;s Stock Tumbles Nearly 15% In 2025

Cathie Wood Buys Amazon, AMD Stock — Trims Palantir, Block Holdings Amid AI And Bitcoin Euphoria

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

ARK 21Shares Bitcoin ETF ARK 21Shares Bitcoin ETF

ARKB

ARKW

RXRX

On Friday, Cathie Wood-led Ark Invest made significant trades involving PLTR, ARKB, and QSI. The PLTR trade sold shares worth $1.6 million, aligning with Ark&#39;s trend of reducing their position in the hot AI stock.

Cathie Wood&#39;s Ark Invest Books Profits On Hot AI Stock Palantir, Sells Bitcoin ETF Shares As BTC Starts 2025 On A Positive Note



In mid-August, around two months after Tempus AI’s (NASDAQ:TEM) initial public offering (IPO), the stock was up a marvelous 93%. However, shares have experienced wild volatility and are now 8% below their opening

Tempus AI: A Potential Double-Bagger After Recent Pullback

Cathie Wood's Wednesday Exodus: Moderna And Jack Dorsey's Block Stocks Get Dumped

TSLA

On Wednesday Dec. 11, 2024, Cathie Wood-led Ark Invest sold $21.8 million worth of Tesla shares.

Cathie Wood&#39;s Ark Invest Trims Tesla Exposure Amid Searing Rally, Sells $21.8M Worth Of Stock — Bets On This AI Medical Company

California,,United,States,-,May,31,2024:,Microsoft,Logo,Displayed

Hedge Funds

AVGO

MSFT

Ray Dalio&#39;s Bridgewaterand Ark Invest trimmed their Microsoft positions, signaling a shift in Big Tech&#39;s role in portfolios.

Ray Dalio&#39;s Bridgewater Cuts Stake In Microsoft Stock By 20% – Is Big Tech Losing Its Shine?

trump-chart-shutter

Large Cap

ALAB

AXON

COIN

DOCS

HOOD

Top-performing large-cap stocks last week: APP (+82.27%), TEM (+49.03%), COIN (+45.35%), ALAB (+42.57%), PLTR (+41.0%), AXON (+39.76%), DOCS (+39.29%), TSLA (+32.28%), HOOD (+25.58%), RDDT (+23.64%).

Donald Trump Victory Week (Nov 4-8): These Large Cap Stocks Were Biggest Gainers

Tempus AI Inc

TEMCO

J.P. Morgan Exchange-Traded Fund Trust JPMorgan Climate Change Solutions ETF

PERSOL HLDG CO LTD ORD by Persol Holdings Co Ltd

Persol Holdings Co Ltd

TEMPLE BAR INVST TR NEW by Temple Bar Investment Trust Plc

TEMPLETON EMRGNG MKT NEW by Templeton Emerging Markets Trust

TEMPUS HLDGS LTD by TEMPUS HLDGS LTD.

Tema ETF Trust Global Royalties ETF

Tema ETF Trust Tema American Reshoring ETF

Tema ETF Trust Tema Luxury ETF

Tema ETF Trust Tema Monopolies and Oligopolies ETF

Tema Electrification ETF

Tema GLP-1, Obesity & Cardiometabolic ETF

Tema Neuroscience and Mental Health ETF

Tema Oncology ETF

TEMAS RESOURCES CORP by Temas Resources Corp.

Temas Resources Corp

Temas Resources Corp Ordinary Shares

TEMECULA VALLEY BNCRP INC by Temecula Valley Bancorp, Inc.

Temecula Valley Bancorp Inc

Temenos AG

Temir Corp

Tempest Therapeutics, Inc. - Common Stock

Tempest Therapeutics Inc

TEMPLE & WEBSTER GRP ORD by Temple & Webster Group Ltd.

Temple & Webster Group Ltd

Templeton Dragon Fund Inc

Templeton Emerging Markets Fund Common Stock

Templeton Emerging Markets Fund

Templeton Emerging Markets Income Fund, Inc. Common Stock

Templeton Emerging Markets Income Fund

Tempo Automation Holdings Inc

TEMPO AUTOMATION HLDGS by Tempo Automation Holdings, Inc.

Tempo Automation Holdings Inc Warrants (22/11/2027)

Tempur Sealy International, Inc. Common Stock

Tempur Sealy International Inc

Morgan Stanley analyst Brian Harbour maintains Domino's Pizza (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DPZ#NASDAQ">DPZ</a>) with a Overweight and lowers the price target from $510 to $496.

Price Target

Analyst Ratings

Morgan Stanley Maintains Overweight on Domino's Pizza, Lowers Price Target to $496

Guidance

UPDATE: Canaan Boosts December Mining to 62 BTC, Projects FY25 Revenue Of $900M-$1.1B

HC Wainwright &amp; Co. analyst Mitchell Kapoor reiterates Summit Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMMT#NASDAQ">SMMT</a>) with a Buy and maintains $44 price target.

Reiteration

SMMT

HC Wainwright & Co. Reiterates Buy on Summit Therapeutics, Maintains $44 Price Target

Mesa Air Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MESA#NASDAQ">MESA</a>) ("Mesa" or the "Company") today announced that it received a notice ("Notice") on January 15, 2025 from the Listing Qualifications Department of The Nasdaq Stock Market ("Nasdaq") stating that the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1) (the "Listing Rule") because the Company failed to timely file its Annual Report on Form 10-K for the fiscal year ended September 30, 2024 (the "Form 10-K") with the Securities and Exchange Commission. The filing delay is not the result of a forthcoming restatement of the Company's financial statements or any disagreement with the Company's auditors.

MESA

Mesa Air Group Receives Non Compliance Notice From Nasdaq

Morgan Stanley analyst John Glass maintains Jack In The Box (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JACK#NASDAQ">JACK</a>) with a Equal-Weight and lowers the price target from $53 to $45.

JACK

Morgan Stanley Maintains Equal-Weight on Jack In The Box, Lowers Price Target to $45

Existing mining operations, constituting the first 400 MW Phase I development at the Corsicana Facility and Riot's Rockdale and Kentucky Facilities – as well as associated expansion plans at these locations – remain in place.
As a result of this action, Riot is reducing its previously announced total self-mining hash rate capacity growth and associated capital expenditures for 2025 and will provide additional updates as this review process progresses further.
&nbsp;

RIOT

Riot Platforms Halts Previously Announced Phase II Bitcoin Mining Expansion At Corsicana Facility; Now Projects Capital Expenditures At The Facility In 2025 To Be Reduced By $245M

Posters include real-world dosing of Tyvaso DPI&#xAE; in pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease, and data from the BREEZE open-label extension study of Tyvaso DPI detailing its long-term outcomes and dosing in patients with pulmonary arterial hypertension&nbsp;
United Therapeutics is sponsoring the Women in PH Luncheon and the Career Catalyst Luncheon: Speed Mentoring for Early Career PH Professionals
United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced that five posters across its commercial and development portfolio in pulmonary hypertension (PH) will be presented at the Pulmonary Vascular Research Institute (PVRI) 2025 Annual Congress taking place January 29 through February 1, 2025 in Rio de Janeiro. In addition, professionals from United Therapeutics will participate in two speaking events associated with the congress.
United Therapeutics is also proud to sponsor the Women in PH Luncheon and the Career Catalyst Luncheon: Speed Mentoring for Early Career PH Professionals.

Biotech

General

UTHR

United Therapeutics To Present Clinical Data Across Its Commercial And Development Portfolio At The Pulmonary Vascular Research Institute 2025 Annual Congress

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li>Citigroup analyst Jason Gursky upgraded the rating for Northrop Grumman Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOC#NYSE">NOC</a>) from Neutral to Buy and maintained the price target of $587. Northrop Grumman shares closed at $482.38 on Friday. <a href="https://www.benzinga.com/quote/noc/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Barclays analyst Benjamin Theurer upgraded FMC Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FMC#NYSE">FMC</a>) from Equal-Weight to Overweight and maintained the price target of $65. FMC shares closed at $53.43 on Friday. <a href="https://www.benzinga.com/quote/fmc/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Evercore ISI Group analyst Durgesh Chopra upgraded the rating for NRG Energy, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NRG#NYSE">NRG</a>) from In-Line to Outperform and raised the price target from $74 to $126. NRG Energy shares closed at $104.51 on Friday. <a href="https://www.benzinga.com/quote/nrg/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Morgan Stanley analyst Simeon Gutman upgraded Ulta Beauty, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ULTA#NASDAQ">ULTA</a>) from Equal-Weight to Overweight and raised the price target from $430 to $500. Ulta Beauty shares closed at $405.01 on Friday. <a href="https://www.benzinga.com/quote/ulta/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Jefferies analyst Surinder Thind upgraded the rating for Genpact Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/G#NYSE">G</a>) from Hold to Buy and raised the price target from $44 to $55. Genpact shares closed at $45.11 on Friday. <a href="https://www.benzinga.com/quote/G/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>
Considering buying ULTA stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="572" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/21072017/image-134-1024x572.png" alt="" class="wp-image-742314" style="width:546px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/21072017/image-134-1024x572.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/21072017/image-134-300x168.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/21072017/image-134-768x429.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/21072017/image-134.png 1087w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/25/01/43091705/top-4-health-care-stocks-you-may-want-to-dump-in-q1">Top 4 Health Care Stocks You May Want To Dump In Q1</a></li>
</ul>

Upgrades

ULTA

This Ulta Beauty Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday

Needham analyst Laura Martin reiterates Outbrain (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OB#NASDAQ">OB</a>) with a Buy and maintains $9 price target.

Needham Reiterates Buy on Outbrain, Maintains $9 Price Target

Wells Fargo analyst Michael Berg downgrades Freshworks (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FRSH#NASDAQ">FRSH</a>) from Equal-Weight to Underweight and lowers the price target from $16 to $13.

Downgrades

FRSH

Wells Fargo Downgrades Freshworks to Underweight, Lowers Price Target to $13

Riot Platforms Seeks Expert Consultants To Assess AI/HPC Opportunities; Plans To Accelerate Engagement With Potential AI/HPC Partners

Morgan Stanley analyst John Glass maintains McDonald's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MCD#NYSE">MCD</a>) with a Overweight and lowers the price target from $340 to $336.

Morgan Stanley Maintains Overweight on McDonald's, Lowers Price Target to $336

Southern States (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SSBK#NASDAQ">SSBK</a>) reported quarterly earnings of $1.04 per share which beat the analyst consensus estimate of $1.00 by 4 percent. This is a 28.4 percent increase over earnings of $0.81 per share from the same period last year.

Earnings

Earnings Beats

SSBK

Southern States Q4 Adj $1.04 Beats $1.00 Estimate

WIIM

Tempus AI shares are trading higher after Nancy Pelosi disclosed the purchase of 50 Jan 2026 call options.

HC Wainwright &amp; Co. analyst Kevin Dede reiterates WonderFi Techs (TSX:<a class="ticker" href="https://www.benzinga.com/stock/WNDR#TSX">WNDR</a>) with a Buy and maintains C$0.5 price target.

TSX:WNDR

HC Wainwright & Co. Reiterates Buy on WonderFi Techs, Maintains C$0.5 Price Target

Offerings

PAR Technology Announces Launch Of $100M Offering

Morgan Stanley analyst Brian Harbour maintains US Foods Hldg (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/USFD#NYSE">USFD</a>) with a Overweight and raises the price target from $76 to $82.

USFD

Morgan Stanley Maintains Overweight on US Foods Hldg, Raises Price Target to $82

New Era Helium, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NEHC#NASDAQ">NEHC</a>) ("NEH," "New Era Helium" or the "Company"), an exploration and production (E&amp;P) company sourcing helium produced in association with natural gas reserves within the Permian Basin, is pleased to announce the finalization of its previously announced 50/50 joint venture ("JV") with Sharon AI, Inc. ("Sharon AI"), a High-Performance Computing business specializing in Artificial Intelligence, Cloud GPU Compute Infrastructure, and Cloud Storage. The newly created joint venture, named Texas Critical Data Centers ("TCDC"), LLC will be a collaboration to fund, develop, and construct a cutting-edge 250MW net-zero energy data center within the Permian Basin.

Contracts

NEHC

New Era Helium And Sharon AI Finalize 50/50 JV To Develop 250MW Net-Zero Energy Data Center In Permian Basin; Site Selection Expected Q1 2025; 20-Year Gas Supply Negotiation Underway; No Financial Terms Disclosed

UBS analyst Priya Sachdeva initiates coverage on Penumbra (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PEN#NYSE">PEN</a>) with a Buy rating and announces Price Target of $305.

Initiation

UBS Initiates Coverage On Penumbra with Buy Rating, Announces Price Target of $305

Redwire Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RDW#NYSE">RDW</a>) shares are trading higher premarket on Tuesday. On Monday, the company inked a deal to <a target="_blank" href="https://www.benzinga.com/pressreleases/25/01/b43086701/redwire-announces-acquisition-of-edge-autonomy-transformational-transaction-creates-a-multi-domain" rel="noreferrer noopener">acquire </a><a target="_blank" href="https://www.benzinga.com/pressreleases/25/01/b43086701/redwire-announces-acquisition-of-edge-autonomy-transformational-transaction-creates-a-multi-domain" rel="noreferrer noopener">Edge Autonomy</a><a target="_blank" href="https://www.benzinga.com/pressreleases/25/01/b43086701/redwire-announces-acquisition-of-edge-autonomy-transformational-transaction-creates-a-multi-domain" rel="noreferrer noopener"> for $925 million</a>.
Formed in 2021 through the merger of UAV Factory and Jennings Aeronautics, Edge Autonomy provides field-proven uncrewed airborne system technology.
The transaction includes $150 million in cash and $775 million in Redwire common stock, based on a 30-day volume-weighted average trading price&nbsp;of $15.07.
Redwire may finance the cash portion using its balance sheet, existing credit facility, or new committed debt facilities, leveraging the expected boost in Adjusted EBITDA and free cash flow.
The company also has the option to raise funds through a new equity issuance, with the issuance price adjusting based on the per-share price of the offering.
The acquisition of Edge Autonomy&#8217;s UAS technology expands Redwire&#8217;s multi-domain coverage, creating integrated solutions that enhance connectivity between space and airborne operations.
The transaction is expected to close in the second quarter of 2025, subject to customary approvals and closing conditions.
Post transaction closure, Edge Autonomy and its subsidiaries will become wholly owned by Redwire.
At closing, Redwire will amend its Investor Rights Agreement with AEI, Genesis Park Holdings, and Edge Autonomy Ultimate Holdings.
AEI can appoint four directors to Redwire&#8217;s Board, reducing if its ownership drops below 50%. Seller can appoint one director as long as it holds at least 25% of its shares.
The agreement also includes a six-month lock-up on share sales for AEI and Seller, with some exceptions.
The deal is expected to be immediately accretive to revenue, Adjusted EBITDA, and Free Cash Flow.
For 2025, the combined company forecasts revenue of $535 million – $605 million and Adjusted EBITDA of $70 million – $105 million, with positive Free Cash Flow, assuming the transaction <a target="_blank" href="https://www.benzinga.com/calendars/guidance" rel="noreferrer noopener">closed on January 1, 2025</a>.
As of September 30, 2024, the company had $43.09 million <a target="_blank" href="https://www.benzinga.com/pressreleases/24/11/b41790012/redwire-corporation-reports-third-quarter-2024-financial-results" rel="noreferrer noopener">in cash and equivalents</a>.
Last week, Redwire disclosed the successful delivery of the fourth pair of Roll-Out Solar Array wings for the <a target="_blank" href="https://www.benzinga.com/pressreleases/25/01/b42941879/redwire-successfully-delivers-fourth-pair-of-roll-out-solar-array-wings-for-iss-power" rel="noreferrer noopener">International Space Station</a>.
Price Action: RDW shares are up 11.1% at $16.40 premarket at the last check Tuesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/content/42971000/these-3-space-stocks-soared-in-2024-can-the-momentum-last" target="_blank" rel="noreferrer noopener">These 3 Space Stocks Soared in 2024: Can the Momentum Last?</a></li>
</ul>
Photo via Shutterstock.

Small Cap

Redwire Rockets Forward With $925M Edge Autonomy Acquisition

In a report released today, Michael Ryskin from Bank of America Securities maintained a Hold rating on Tempus AI, Inc. Class A (TEM – Research Repo...

Tempus AI: Balancing Promising Growth with Current Performance Shortfalls

20:11 EST Cathie Wood's ARK Investment bought 379K shares of Tempus AI (TEM) today Published first on TheFly – the ultimate source for real-time, m...

Cathie Wood's ARK Investment bought 379K shares of Tempus AI today

Cathie Wood's ARK Investment loaded up on more shares of medical technology business Tempus AI ($TEM) on Monday, January 13th, as the stock took a ...

Cathie Wood's ARKG Loads Up on Tempus AI (NASDAQ:TEM) as Stock Plunges on Revenue Miss

Loop Capital lowered the firm's price target on Tempus AI (TEM) to $52 from $57 and keeps a Buy rating on the shares. The firm cites the company's ...

Tempus AI price target lowered to $52 from $57 at Loop Capital

Tempus AI: Disappointing Q4 Preliminary Results, But Bullish Fundamental Update

Tempus AI (TEM) announced the national launch of the company's FDA-approved, NGS-based in vitro diagnostic device, xT CDx. Beginning today, xT CDx ...

Tempus AI announces national launch of FDA-approved xT CDx test

Healwell AI: Buy This AI Penny Stock Before The Rush

Latest data shows the largest indicative borrow rate increases among liquid option names include: Toronto Dominion Bank (TD) 1.59% +1.10, Aehr Test...

Largest borrow rate increases among liquid names

20:13 EST Cathie Wood's ARK Investment bought 186.5K shares of Tempus AI (TEM) today Published first on TheFly – the ultimate source for real-time,...

Cathie Wood's ARK Investment bought 186.5K shares of Tempus AI today

Bradley Keywell, a major owner (more than 10% stake) of Tempus AI, Inc. Class A ($TEM) shares, sold common stock worth $33.13 million in the last w...

Government Trades

Tempus AI Inc

top performing TEM trades

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga